Fly News Breaks for May 30, 2019
May 30, 2019 | 07:29 EDT
BMO Capital analyst Joanne Wuensch raised her price target on Boston Scientific to $46 from $44 while keeping the stock at Outperform and adding the name to her Top Picks list. The analyst notes that the company's guidance for 2019 has been reset after a Q1 earnings miss but sees "several upcoming catalysts", including its June 26th analyst meeting that will feature a pipeline update, its FDA Paclitaxel Panel as soon as next month, and the closing of its BTG acquisition. Wuensch further cites Boston Scientific's high-single-digit organic revenue and and double-digit EPS growth along with its operating leverage.
News For BSX From the Last 2 Days
Jul 23, 2019 | 14:16 EDT
Notable companies reporting before tomorrow's open, with earnings consensus, include AT&T (T), consensus 89c... Boeing (BA), consensus $1.87... Thermo Fisher Scientific (TMO), consensus $3... NextEra Energy (NEE), consensus $2.31... UPS (UPS), consensus $1.92... Anthem (ANTM), consensus $4.61... Caterpillar (CAT), consensus $3.12... Boston Scientific (BSX), consensus 38c... Northrop Grumman (NOC), consensus $4.68... General Dynamics (GD), consensus $2.68... V.F. Corp (VFC), consensus 29c... Amphenol (APH), consensus 93c... Hilton (HLT), consensus $1.02... Freeport-McMoRan (FCX), consensus (5c)... Santander Consumer (SC), consensus 91c... Knight-Swift Transportation (KNX), consensus 58c.